These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases. Mesitskaya DF; Syrkin AL; Aksenova MG; Zhang Y; Zamyatnin AA; Kopylov PY Cardiovasc Hematol Agents Med Chem; 2018; 16(2):81-87. PubMed ID: 30039765 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R; Mezzasoma AM; Venditti G; Gresele P Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439 [TBL] [Abstract][Full Text] [Related]
4. The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Ekambaram P; Lambiv W; Cazzolli R; Ashton AW; Honn KV Cancer Metastasis Rev; 2011 Dec; 30(3-4):397-408. PubMed ID: 22037941 [TBL] [Abstract][Full Text] [Related]
5. New developments on thromboxane modulators. Dogné JM; Hanson J; de Leval X; Masereel B; Kolh P; Pirotte B Mini Rev Med Chem; 2004 Aug; 4(6):649-57. PubMed ID: 15279599 [TBL] [Abstract][Full Text] [Related]
6. [Thromboxane A2 receptor; structure, function and tissue distribution]. Namba T; Narumiya S Nihon Rinsho; 1993 Jan; 51(1):233-40. PubMed ID: 8433523 [TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721 [TBL] [Abstract][Full Text] [Related]
9. Thromboxane synthase: structure and function of protein and gene. Wang LH; Kulmacz RJ Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():409-22. PubMed ID: 12432933 [No Abstract] [Full Text] [Related]
11. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists. Dickinson RP; Dack KN; Long CJ; Steele J J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919 [TBL] [Abstract][Full Text] [Related]
12. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. Raychowdhury MK; Yukawa M; Collins LJ; McGrail SH; Kent KC; Ware JA J Biol Chem; 1994 Jul; 269(30):19256-61. PubMed ID: 8034687 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological action on the thromboxane and prostacyclin balance in the body]. Lakin KM; Makarov VA; Novikova NV; Tret'iak VM; Rukazenkov IuE Farmakol Toksikol; 1984; 47(2):67-79. PubMed ID: 6425078 [No Abstract] [Full Text] [Related]
14. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191. Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817 [TBL] [Abstract][Full Text] [Related]
16. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors. Sprague PW; Heikes JE; Harris DN; Greenberg R Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073 [No Abstract] [Full Text] [Related]
17. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. Fontana P; Alberts P; Sakariassen KS; Bounameaux H; Meyer JP; Santana Sorensen A J Thromb Haemost; 2011 Oct; 9(10):2109-11. PubMed ID: 21777369 [No Abstract] [Full Text] [Related]
18. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway. Tobias LD; Hamilton JG Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605 [No Abstract] [Full Text] [Related]
19. Thromboxane A2 synthesis in human erythroleukemia cells. Jones DA; Fitzpatrick FA; Malcolm KC Biochem Biophys Res Commun; 1991 Oct; 180(1):8-14. PubMed ID: 1930241 [TBL] [Abstract][Full Text] [Related]
20. Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood. Pierson RN; Parker RE Transplant Proc; 1996 Apr; 28(2):625. PubMed ID: 8623309 [No Abstract] [Full Text] [Related] [Next] [New Search]